Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis (Q35079589)

6 August 2017

Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis (English)

1 reference

6 August 2017

2

K Rajender Reddy

1 reference

6 August 2017

12

Jasmohan S Bajaj

1 reference

6 August 2017

Jacqueline G O'Leary

1

1 reference

6 August 2017

Florence Wong

3

1 reference

6 August 2017

Patrick S Kamath

4

1 reference

6 August 2017

Heather M Patton

5

1 reference

6 August 2017

Scott W Biggins

6

1 reference

6 August 2017

Michael B Fallon

7

1 reference

6 August 2017

Guadalupe Garcia-Tsao

8

1 reference

6 August 2017

Ram M Subramanian

9

1 reference

6 August 2017

Raza Malik

10

1 reference

6 August 2017

Leroy R Thacker

11

1 reference

6 August 2017

North American Consortium for the Study of End-Stage Liver Disease

13

1 reference

6 August 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

Clinical Gastroenterology and Hepatology

6 August 2017

1 reference

6 August 2017

13

1 reference

6 August 2017

753-9.e1-2

1 reference

6 August 2017

4

1 reference

New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Subsequent infections in survivors of sepsis: epidemiology and outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Experience Since MELD Implementation: How Does the New System Deliver?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Bacterial infections in end-stage liver disease: current challenges and future directions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Management of bacterial infections in cirrhosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Spontaneous bacterial peritonitis: recent guidelines and beyond

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Liver transplantation in patients with liver cirrhosis and active pneumonia: an observational study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Immune dysfunction and infections in patients with cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Chronic sepsis mortality characterized by an individualized inflammatory response

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Bacterial infection-related morbidity and mortality in cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Bacterial translocation (BT) in cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Sepsis syndromes: understanding the role of innate and acquired immunity.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Overuse of proton pump inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Long-term survival and function after suspected gram-negative sepsis.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326601

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

27 September 2018

1 reference

12 December 2020

Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections

1 reference

12 December 2020

The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis

1 reference

12 December 2020

Sir Isaac Newton, sepsis, SIRS, and CARS

1 reference

12 December 2020

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

1 reference

12 December 2020

Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis

1 reference

12 December 2020

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

1 reference

12 December 2020

Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites

1 reference

12 December 2020

Three-year outcomes for Medicare beneficiaries who survive intensive care

1 reference

12 December 2020

10.1016/J.CGH.2014.07.060

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference